{"id":"https://openalex.org/W1963482722","doi":"https://doi.org/10.4088/pcc.v08n0404","title":"The Safety and Tolerability of Duloxetine Compared With Paroxetine and Placebo: A Pooled Analysis of 4 Clinical Trials","display_name":"The Safety and Tolerability of Duloxetine Compared With Paroxetine and Placebo: A Pooled Analysis of 4 Clinical Trials","alternate_titles":[],"publication_year":2006,"publication_date":"2006-08-15","ids":{"openalex":"https://openalex.org/W1963482722","doi":"https://doi.org/10.4088/pcc.v08n0404","mag":"1963482722","pmid":"https://pubmed.ncbi.nlm.nih.gov/16964316","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1557468"},"language":"en","primary_location":{"id":"doi:10.4088/pcc.v08n0404","doi":"https://doi.org/10.4088/pcc.v08n0404","is_oa":true,"landing_page_url":"https://doi.org/10.4088/pcc.v08n0404","pdf_url":"https://www.psychiatrist.com/read-pdf/23162","source":{"id":"https://openalex.org/S4210179967","display_name":"The Primary Care Companion For CNS Disorders","issn_l":"2155-7780","issn":["2155-7780","2155-7772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Primary Care Companion For CNS Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1963482722"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.psychiatrist.com/read-pdf/23162","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020484968","display_name":"J. Craig Nelson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Craig Nelson","raw_affiliation_strings":["Department of Psychiatry, University of California at San Francisco, San Francisco, CA, USA. craign@lppi.ucsf.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of California at San Francisco, San Francisco, CA, USA. craign@lppi.ucsf.edu","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034584090","display_name":"Yili Pritchett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]},{"id":"https://openalex.org/I3019813218","display_name":"Abbott (United Kingdom)","ror":"https://ror.org/03wnay029","country_code":"GB","type":"company","lineage":["https://openalex.org/I3019813218","https://openalex.org/I4210088555"]},{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yili Lu  Pritchett","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, Ill.,","Amylin Pharmaceuticals, Inc., San Diego, Calif","Department of Psychiatry, University of California at San Francisco, San Francisco (Dr. Nelson);","Department of Psychiatry, University of California at San Francisco, San Francisco, CA 94143","Detke); Department of Psychiatry, Indiana University School of Medicine, Indianapolis (Dr. Detke); Department of Psychiatry,","Harvard Medical School, Boston, Mass","Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Ind","McLean Hospital, Belmont, Mass. (Dr. Detke); and Department of Psychiatry,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, Ill.,","institution_ids":["https://openalex.org/I3019813218"]},{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, Calif","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry, University of California at San Francisco, San Francisco (Dr. Nelson);","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Department of Psychiatry, University of California at San Francisco, San Francisco, CA 94143","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Detke); Department of Psychiatry, Indiana University School of Medicine, Indianapolis (Dr. Detke); Department of Psychiatry,","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Mass","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Ind","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"McLean Hospital, Belmont, Mass. (Dr. Detke); and Department of Psychiatry,","institution_ids":["https://openalex.org/I2801148111"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Oleg Martynov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]},{"id":"https://openalex.org/I3019813218","display_name":"Abbott (United Kingdom)","ror":"https://ror.org/03wnay029","country_code":"GB","type":"company","lineage":["https://openalex.org/I3019813218","https://openalex.org/I4210088555"]},{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Oleg Martynov","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, Ill.,","Amylin Pharmaceuticals, Inc., San Diego, Calif","Department of Psychiatry, University of California at San Francisco, San Francisco (Dr. Nelson);","Department of Psychiatry, University of California at San Francisco, San Francisco, CA 94143","Detke); Department of Psychiatry, Indiana University School of Medicine, Indianapolis (Dr. Detke); Department of Psychiatry,","Harvard Medical School, Boston, Mass","Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Ind","McLean Hospital, Belmont, Mass. (Dr. Detke); and Department of Psychiatry,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, Ill.,","institution_ids":["https://openalex.org/I3019813218"]},{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, Calif","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry, University of California at San Francisco, San Francisco (Dr. Nelson);","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Department of Psychiatry, University of California at San Francisco, San Francisco, CA 94143","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Detke); Department of Psychiatry, Indiana University School of Medicine, Indianapolis (Dr. Detke); Department of Psychiatry,","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Mass","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Ind","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"McLean Hospital, Belmont, Mass. (Dr. Detke); and Department of Psychiatry,","institution_ids":["https://openalex.org/I2801148111"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019792753","display_name":"Jimmy Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]},{"id":"https://openalex.org/I3019813218","display_name":"Abbott (United Kingdom)","ror":"https://ror.org/03wnay029","country_code":"GB","type":"company","lineage":["https://openalex.org/I3019813218","https://openalex.org/I4210088555"]},{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["GB","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jimmy Y. Yu","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, Ill.,","Amylin Pharmaceuticals, Inc., San Diego, Calif","Department of Psychiatry, University of California at San Francisco, San Francisco (Dr. Nelson);","Department of Psychiatry, University of California at San Francisco, San Francisco, CA 94143","Detke); Department of Psychiatry, Indiana University School of Medicine, Indianapolis (Dr. Detke); Department of Psychiatry,","Harvard Medical School, Boston, Mass","Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Ind","McLean Hospital, Belmont, Mass. (Dr. Detke); and Department of Psychiatry,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, Ill.,","institution_ids":["https://openalex.org/I3019813218"]},{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, Calif","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry, University of California at San Francisco, San Francisco (Dr. Nelson);","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Department of Psychiatry, University of California at San Francisco, San Francisco, CA 94143","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Detke); Department of Psychiatry, Indiana University School of Medicine, Indianapolis (Dr. Detke); Department of Psychiatry,","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Mass","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Ind","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"McLean Hospital, Belmont, Mass. (Dr. Detke); and Department of Psychiatry,","institution_ids":["https://openalex.org/I2801148111"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042304299","display_name":"Craig H. Mallinckrodt","orcid":"https://orcid.org/0000-0002-8462-6320","observed_orcids":["https://orcid.org/0000-0002-8462-6320"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]},{"id":"https://openalex.org/I3019813218","display_name":"Abbott (United Kingdom)","ror":"https://ror.org/03wnay029","country_code":"GB","type":"company","lineage":["https://openalex.org/I3019813218","https://openalex.org/I4210088555"]},{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Craig H. Mallinckrodt","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, Ill.,","Amylin Pharmaceuticals, Inc., San Diego, Calif","Department of Psychiatry, University of California at San Francisco, San Francisco (Dr. Nelson);","Department of Psychiatry, University of California at San Francisco, San Francisco, CA 94143","Detke); Department of Psychiatry, Indiana University School of Medicine, Indianapolis (Dr. Detke); Department of Psychiatry,","Harvard Medical School, Boston, Mass","Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Ind","McLean Hospital, Belmont, Mass. (Dr. Detke); and Department of Psychiatry,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, Ill.,","institution_ids":["https://openalex.org/I3019813218"]},{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, Calif","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry, University of California at San Francisco, San Francisco (Dr. Nelson);","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Department of Psychiatry, University of California at San Francisco, San Francisco, CA 94143","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Detke); Department of Psychiatry, Indiana University School of Medicine, Indianapolis (Dr. Detke); Department of Psychiatry,","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Mass","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Ind","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"McLean Hospital, Belmont, Mass. (Dr. Detke); and Department of Psychiatry,","institution_ids":["https://openalex.org/I2801148111"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113644572","display_name":"Michael J. Detke","orcid":"https://orcid.org/0000-0002-2195-8651","observed_orcids":["https://orcid.org/0000-0002-2195-8651"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael J. Detke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5019792753"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I168537998","https://openalex.org/I180670191","https://openalex.org/I2801148111","https://openalex.org/I3019813218","https://openalex.org/I4388446366","https://openalex.org/I4394709130"],"apc_list":null,"apc_paid":null,"fwci":2.5497,"has_fulltext":true,"cited_by_count":50,"citation_normalized_percentile":{"value":0.88330171,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"8","issue":"4","first_page":"212","last_page":"219"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/duloxetine","display_name":"duloxetine","score":1.0},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":1.0},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9950000047683716},{"id":"https://openalex.org/keywords/antidepressant-safety","display_name":"antidepressant safety","score":0.8159999847412109},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.8550000190734863},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7649999856948853},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.8659999966621399},{"id":"https://openalex.org/keywords/qtc-interval","display_name":"QTc interval","score":0.8629999756813049},{"id":"https://openalex.org/keywords/heart-rate","display_name":"heart rate","score":0.8730000257492065},{"id":"https://openalex.org/keywords/sexual-dysfunction","display_name":"sexual dysfunction","score":0.9670000076293945},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.949999988079071},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C2780764818","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine","level":3,"score":0.9252832531929016},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7968472242355347},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.7928335070610046},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7748515605926514},{"id":"https://openalex.org/C2910564767","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine Hydrochloride","level":4,"score":0.6665039658546448},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.507567286491394},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5021679401397705},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48181596398353577},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4723024368286133},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.43005478382110596},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4273243546485901},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.4129871726036072},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.15467354655265808},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.4088/pcc.v08n0404","doi":"https://doi.org/10.4088/pcc.v08n0404","is_oa":true,"landing_page_url":"https://doi.org/10.4088/pcc.v08n0404","pdf_url":"https://www.psychiatrist.com/read-pdf/23162","source":{"id":"https://openalex.org/S4210179967","display_name":"The Primary Care Companion For CNS Disorders","issn_l":"2155-7780","issn":["2155-7780","2155-7772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Primary Care Companion For CNS Disorders","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1557468","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1557468/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Prim Care Companion J Clin Psychiatry","raw_type":"Text"},{"id":"pmid:16964316","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16964316","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Primary care companion to the Journal of clinical psychiatry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4088/pcc.v08n0404","doi":"https://doi.org/10.4088/pcc.v08n0404","is_oa":true,"landing_page_url":"https://doi.org/10.4088/pcc.v08n0404","pdf_url":"https://www.psychiatrist.com/read-pdf/23162","source":{"id":"https://openalex.org/S4210179967","display_name":"The Primary Care Companion For CNS Disorders","issn_l":"2155-7780","issn":["2155-7780","2155-7772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Primary Care Companion For CNS Disorders","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1963482722.pdf","grobid_xml":"https://content.openalex.org/works/W1963482722.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W51209413","https://openalex.org/W1545716081","https://openalex.org/W1971393265","https://openalex.org/W1974946748","https://openalex.org/W1978829273","https://openalex.org/W2002519594","https://openalex.org/W2003363634","https://openalex.org/W2018425549","https://openalex.org/W2021189780","https://openalex.org/W2047902057","https://openalex.org/W2069090735","https://openalex.org/W2071214152","https://openalex.org/W2074133854","https://openalex.org/W2081788234","https://openalex.org/W2085470365","https://openalex.org/W2099564543","https://openalex.org/W2101820523","https://openalex.org/W2114613490","https://openalex.org/W2119660434","https://openalex.org/W2141662431","https://openalex.org/W2164182651","https://openalex.org/W2322333115","https://openalex.org/W2410702893","https://openalex.org/W2415625988","https://openalex.org/W2518591233","https://openalex.org/W2800259946","https://openalex.org/W3090293687"],"related_works":["https://openalex.org/W2084168719","https://openalex.org/W2098354008","https://openalex.org/W2373004272","https://openalex.org/W2000769256","https://openalex.org/W1995650316","https://openalex.org/W1989302385","https://openalex.org/W2193734995","https://openalex.org/W2076012649","https://openalex.org/W2047902057","https://openalex.org/W1982721912"],"abstract_inverted_index":{"BACKGROUND:":[0],"To":[1],"compare":[2,40],"the":[3,41,58,88,109,139,148,163,167,180,227,246,256],"safety":[4,42,274],"and":[5,11,28,43,104,125,133,153,191,202,266,275],"tolerability":[6,44,276],"of":[7,31,45,57,170,234,280],"duloxetine":[8,32,46,116,149,201],"with":[9,15,51,271,273],"paroxetine":[10,52,164],"placebo":[12,247],"in":[13,87,147,162,175,213,217,240,245,269],"patients":[14,71,193,196,215,219,270],"major":[16],"depressive":[17],"disorder":[18],"(MDD).":[19],"METHOD:":[20],"Data":[21],"from":[22,160],"four":[23],"8-week":[24],"randomized,":[25],"double-blind,":[26],"placebo-":[27],"paroxetine-controlled":[29],"studies":[30],"for":[33,94,101,115,138],"MDD":[34],"(DSM-IV":[35],"criteria)":[36],"were":[37,131],"pooled":[38,67],"to":[39,48,278],"40":[47],"120":[49],"mg/day":[50],"20":[53],"mg":[54],"q.d.":[55],"Two":[56],"4":[59],"trials":[60],"included":[61,69],"a":[62],"26-week":[63],"extension.":[64],"RESULTS:":[65],"The":[66],"database":[68],"1466":[70],"(duloxetine,":[72,117,249],"N":[73,77,81],"=":[74,78,82,198,224],"736;":[75],"paroxetine,":[76,105,119,251],"359;":[79],"placebo,":[80,121,253],"371).":[83],"No":[84],"deaths":[85],"occurred":[86],"acute":[89],"phase":[90],"trials.":[91],"Discontinuation":[92],"rates":[93],"adverse":[95,113],"events":[96],"did":[97,134,154,259],"not":[98,135,260],"differ":[99,136,155],"significantly":[100,137,156,187,211],"duloxetine,":[102],"8.0%,":[103],"6.1%.":[106],"Nausea":[107],"was":[108,186,210,238],"most":[110],"frequent":[111],"treatment-emergent":[112],"event":[114],"14.4%;":[118],"12.0%;":[120],"3.8%).":[122],"Blood":[123],"pressure":[124],"corrected":[126],"QT":[127],"(QTc)":[128],"interval":[129],"changes":[130,174],"modest":[132],"3":[140],"groups.":[141],"Mean":[142,173],"heart":[143],"rate":[144],"increased":[145],"slightly":[146],"group,":[150,165],"1.0":[151],"beat/minute,":[152],"(p":[157,197],"<":[158,204],".001)":[159],"that":[161,279],"but":[166,255],"change":[168],"is":[169,264],"doubtful":[171],"importance.":[172],"laboratory":[176],"analytes":[177],"remained":[178],"within":[179],"reference":[181],"range.":[182],"Emergent":[183],"sexual":[184],"dysfunction":[185],"greater":[188,239],"among":[189],"duloxetine-":[190],"paroxetine-treated":[192,218],"than":[194,216,244],"placebo-treated":[195],".007":[199],"vs.":[200,206,221],"p":[203,223],".001":[205],"paroxetine);":[207],"however,":[208],"it":[209],"lower":[212],"duloxetine-treated":[214],"(46.4%":[220],"61.4%;":[222],".015).":[225],"During":[226],"extension":[228],"phase,":[229],"weight":[230],"gain":[231],"(\u2265":[232],"7%":[233],"initial":[235],"body":[236],"weight)":[237],"both":[241],"active-treatment":[242,257],"groups":[243,258],"group":[248],"10.8%;":[250],"13.8%;":[252],"3.1%),":[254],"differ.":[261],"CONCLUSIONS:":[262],"Duloxetine":[263],"safe":[265],"well":[267],"tolerated":[268],"MDD,":[272],"comparable":[277],"paroxetine.":[281]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1963482722","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
